- Home
- NPT vs CNTX Comparison
NPT vs CNTX Comparison
Compare NPT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPT
- CNTX
- Stock Information
- Founded
- NPT 2011
- CNTX 2015
- Country
- NPT China
- CNTX United States
- Employees
- NPT N/A
- CNTX N/A
- Industry
- NPT Specialty Chemicals
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- NPT Consumer Discretionary
- CNTX Health Care
- Exchange
- NPT Nasdaq
- CNTX Nasdaq
- Market Cap
- NPT 113.1M
- CNTX 102.9M
- IPO Year
- NPT 2025
- CNTX 2021
- Fundamental
- Price
- NPT $3.69
- CNTX $1.18
- Analyst Decision
- NPT
- CNTX Strong Buy
- Analyst Count
- NPT 0
- CNTX 7
- Target Price
- NPT N/A
- CNTX $5.40
- AVG Volume (30 Days)
- NPT 130.5K
- CNTX 252.2K
- Earning Date
- NPT 11-18-2025
- CNTX 11-05-2025
- Dividend Yield
- NPT N/A
- CNTX N/A
- EPS Growth
- NPT N/A
- CNTX N/A
- EPS
- NPT N/A
- CNTX N/A
- Revenue
- NPT $797,148,640.00
- CNTX N/A
- Revenue This Year
- NPT N/A
- CNTX N/A
- Revenue Next Year
- NPT N/A
- CNTX N/A
- P/E Ratio
- NPT N/A
- CNTX N/A
- Revenue Growth
- NPT 18.51
- CNTX N/A
- 52 Week Low
- NPT $3.14
- CNTX $0.49
- 52 Week High
- NPT $9.18
- CNTX $1.74
- Technical
- Relative Strength Index (RSI)
- NPT N/A
- CNTX 51.27
- Support Level
- NPT N/A
- CNTX $1.07
- Resistance Level
- NPT N/A
- CNTX $1.19
- Average True Range (ATR)
- NPT 0.00
- CNTX 0.09
- MACD
- NPT 0.00
- CNTX -0.01
- Stochastic Oscillator
- NPT 0.00
- CNTX 69.44
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.